1 REPORT SCOPE
1.1 SCOPE OF THE STUDY
1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE
1.1.2 XX RESEARCH METHODOLOGY
1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY
1.1.3.1 Geographical Analysis
1.1.3.2 Demand Side & Supply Side Analysis
1.1.3.3 Data Synthesis & Bridging
1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY
1.1.5 KEY DATA POINT SOURCES
1.1.5.1 Data Points taken from Secondary Sources
1.1.5.2 Data Points taken from Primary Sources
1.1.6 REPORT DESCRIPTION
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 MARKET DRIVERS
3.2.1.1 Patients Involvement in personal healthcare
3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare
3.2.1.3 Integration of wireless technologies with portable healthcare devices
3.2.1.4 Introduction of connected healthcare solutions in the mHealth market
3.2.1.5 Benefits of Cost effectiveness and Patients’ Convenience
3.2.1.6 Increase in Lifestyle Disease
3.2.2 MARKET CHALLENGES
3.2.2.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs)
3.2.2.2 Invasion of Privacy
3.2.2.2.1 Security Breach Cases
3.2.2.2.2 Potential risk of Hardware or Software failure
3.2.2.2.3 Stringent Regulations and Standards
3.2.2.2.4 Lack of Awareness about the possible applications of mHealth
3.2.3 MARKET OPPORTUNITIES
3.2.3.1 Partnership: An entry mode
3.2.3.2 Introduction of mHealth in developing economies
4 INDUSTRY DYNAMICS
4.1 MHEALTH MARKET TIMELINE
4.2 VALUE CHAIN OF THE MHEALTH MARKET
4.2.1.1 Device Manufacturers
4.2.1.2 App Developers
4.2.1.3 Network providers/ Mobile operators
4.2.1.4 Healthcare providers and Pharmaceuticals
4.2.1.5 Patients
4.2.1.6 Consortiums, Certification, Regulations, & Standards
4.2.1.6.1 Introduction
4.2.1.6.2 Consortiums
4.2.1.6.3 Alliance/Associations
4.2.1.6.4 Regulatory Bodies
4.2.1.7 Food and Drug Administration (FDA)
4.2.1.8 Medical Device Regulation Act
4.2.1.9 Medical Mobile Application(MMA)
4.2.2 CERTIFICATION
4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS
4.2.4 BARGAINING POWER OF BUYER
4.2.5 BARGAINING POWER OF SUPPLIER
4.2.6 THREAT FROM SUBSTITUTE
4.2.7 THREAT FROM A NEW ENTRANT
4.2.8 INTENSITY OF COMPETITIVE RIVALRY
5 GLOBAL MHEALTH MARKET ECOSYSTEM
5.1 INTRODUCTION
5.1.1 MHEALTH DEVICES
5.1.2 MEDICAL DEVICES
5.1.2.1 SMBG monitor
5.1.2.1.1 SMBG Device Types& Uses
5.1.2.1.2 Diseases Managed by SMBG Device
5.1.2.1.3 Key players
5.1.2.2 Blood Pressure (BP) Monitor
5.1.2.2.1 BP Monitor Device Types & Uses
5.1.2.2.2 Diseases Managed by BP Monitor Device
5.1.2.2.3 Key players
5.1.2.2.4 Pulse Oximeter
5.1.2.2.5 Pulse Oximeter : Types & Uses
5.1.2.2.6 Diseases Managed by Pulse Oximeter Device
5.1.2.2.7 Key players
5.1.2.3 Cardiac Monitors
5.1.2.3.1 Diseases Managed by Cardiac Monitors
5.1.2.3.2 Disease Management Devices Types
5.1.2.3.3 Cardiac Monitor Uses
5.1.2.4 Key players
5.1.2.5 Other medical devices
5.1.2.5.1 Health and Fitness Devices
5.1.2.5.2 Hand Worn Products
5.1.2.5.2.1 Smart Watch
5.1.2.5.2.2 Wrist Wear
5.1.2.5.3 Key players
5.1.2.5.4 Head Worn Products
5.1.2.5.4.1 AR/VR HMD/HUD
5.1.2.5.4.2 Others
5.1.2.5.4.3 Body worn products
5.1.2.5.4.4 Smart Textile
5.1.2.5.4.5 Wearable Patch
5.1.2.5.4.6 Others
5.1.2.5.5 Non-Clinical applications
5.1.2.5.6 Clinical Application
5.1.2.6 Others Devices
5.1.2.6.1 Mobile telemedicine/tele-care devices
5.1.2.6.2 Home care devices
5.1.2.6.2.1 Vessyl
5.1.2.6.2.2 TAO
5.1.2.6.2.3 CubeSensors
5.1.2.6.2.4 Kolibree
5.1.2.6.2.5 TellSpec
5.1.2.6.2.6 Kinsa
5.1.2.6.2.7 Beddit
5.1.2.6.2.8 Wello iPhone Case
5.1.2.6.3 Key Participants
5.1.2.7 mHealth Services
5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION
5.1.3.1 Software
5.1.3.2 Big data
5.1.3.3 Key Market Trends, Developments and Participants
5.1.3.3.1 Market Trends and Market Developments
5.1.3.3.2 Key Participants
5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS
5.1.4.1 Benefits of network & Services
5.1.4.2 Key Market Trends, Developments and Participants
5.1.4.2.1 Market Trends and Market Developments
5.1.4.2.2 Key Participants
5.1.5 HEALTHCARE AND PHARMACEUTICALS
5.1.5.1 Healthcare providers
5.1.5.2 Pharmaceuticals
5.1.5.2.1 Key Market Trends, Developments and Participants
5.1.5.2.1.1 Market Trends and Market Developments
5.1.5.2.1.2 Key Participants
6 GLOBAL MHEALTHMARKET – THERAPEUTICS
6.1 INTRODUCTION
6.1.1 GLOBAL MARKET STATISTICS
6.1.1.1 Cardiovascular Diseases
6.1.2 DEVICES
6.1.3 APPS
6.1.4 KEY PLAYERS
6.2 DIABETES
6.2.1 DEVICES
6.2.2 APPS
6.2.3 KEY PLAYERS
6.3 RESPIRATORY
6.3.1 DEVICES
6.3.2 APPS
6.3.3 KEY PLAYERS
6.4 MENTAL AND NEUROLOGICAL DISORDERS
6.4.1 DEVICES
6.4.2 APPS
6.4.3 KEY PLAYERS
6.5 FITNESS & LIFESTYLE THERAPEUTICS
6.5.1 DEVICES
6.5.2 APPS
6.5.3 KEY PLAYERS
6.6 OTHERS
7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE
7.1 INTRODUCTION
7.1.1 MONITORING APPLICATIONS
7.1.1.1 Key Participants
7.1.2 DIAGNOSIS & TREATMENT
7.1.2.1 Key Participants
7.1.3 EDUCATION AND AWARENESS
7.1.3.1 Key Participants
7.1.4 HEALTHCARE MANAGEMENT
7.1.5 WELLNESS & PREVENTION
7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET
7.1.7 REMOTE DATA COLLECTION
7.1.7.1 Key Market Developments
8 GLOBAL MHEALTH MARKET–GEOGRAPHY
8.1 INTRODUCTION
8.1.1 MARKET STATISTICS
8.1.2 THE AMERICAS
8.1.3 NORTH AMERICA
8.1.3.1 U.S.
8.1.3.1.1 Key Market trends, Developments and Participants
8.1.3.1.1.1 Key Market Trends and Developments
8.1.3.1.1.2 Key Participants
8.1.3.2 Canada
8.1.3.2.1 Key Market Trend
8.1.3.2.2 Key players
8.1.3.3 South America
8.1.3.3.1 Constraints
8.1.3.3.2 Key Market Trends, Developments and Participants
8.1.3.3.2.1 Market Trends and Market Developments
8.1.3.3.2.2 Key Participants
8.1.4 ASIA-PACIFIC (APAC)
8.1.4.1 Key Drivers in APAC
8.1.4.1.1 Key Market Trends, Developments and Participants
8.1.4.1.1.1 Market Trends & Development
8.1.4.1.1.2 Key Participants
8.1.4.2 CHINA
8.1.4.3 JAPAN
8.1.4.4 AUSTRALIA
8.1.4.5 INDIA
8.1.5 EUROPE
8.1.5.1 Key Market Trends, Developments and Participants
8.1.5.2 The U.K.
8.1.5.3 Germany
8.1.5.4 Key Participants
8.1.6 REST OF THE WORLD (ROW)
8.1.6.1 Africa
8.1.6.1.1 Key Market Trends, Developments and Participants
8.1.6.1.1.1 Market Trends and Market Developments
8.1.6.1.2 Key Participants
8.1.7 MIDDLE EAST
8.1.7.1 Key Market Trends, Developments and Participants
8.1.7.1.1 Market Trends and Market Developments
8.1.7.1.2 Key Participants
9 KEY MARKET DEVELOPMENT AND STRATEGIES
9.1 INTRODUCTION
9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.1.2 MERGERS & ACQUISITIONS
9.1.3 PRODUCT DEVELOPMENT AND LAUNCH
9.1.4 BUSINESS EXPANSION/CONTRACTS
9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS
9.1.6 OTHERS (EVENTS & RECOGNITIONS)
10 COMPANY PROFILES
1.1 AGAMATRIX, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 KEY DEVELOPMENTS
10.2 ALIVECOR, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 KEY DEVELOPMENTS
10.3 APPLE, INC.
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.2.1 Overall Financials
10.3.2.2 Financials By Segment
10.3.2.3 Financials By Region
10.3.2.4 Financial Summary
10.3.3 KEY DEVELOPMENT
10.4 ATHENAHEALTH INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.2.1 Overall Financials
10.4.2.2 Financial by Segments
10.4.2.3 Financial Summary
10.4.3 KEY DEVELOPMENT
10.5 AT&T, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.2.1 Overall Financials
10.5.2.2 Financials By Segment
10.5.2.3 Financial Summary
10.5.3 KEY DEVELOPMENTS
10.6 BIOTELEMETRY, INC. (CARDIONET)
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.2.1 Overall Financials
10.6.2.2 Financials by Segment
10.6.2.3 Financial Summary
10.6.3 KEY DEVELOPMENTS
10.7 GE HEALTHCARE
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.2.1 Overall Financials
10.7.2.2 Financials by Segment
10.7.2.3 Financial Summary
10.7.3 KEY DEVELOPMENTS
10.8 GOOGLE INC.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.2.1 Financial Summary
10.8.3 KEY DEVELOPMENTS
10.9 JAWBONE, INC.
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 KEY DEVELOPMENTS
10.1 JOHNSON & JOHNSON
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.2.1 Overall Financials
10.10.2.2 Net Revenue By Segment
10.10.2.3 Net revenue by Region
10.10.3 KEY DEVELOPMENTS
10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.2.1 Overall Financials
10.11.2.2 Financials by Segment
10.11.2.3 Financial Summary
10.11.3 KEY DEVELOPMENTS
10.12 MEDTRONIC PLC
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.2.1 Overall Financials
10.12.2.2 Financial Summary
10.12.3 KEY DEVELOPMENTS
10.13 NIKE INC.
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.2.1 Overall Financials
10.13.2.2 Financials by Segments
10.13.2.3 Financial Summary
10.13.3 KEY DEVELOPMENTS
10.14 PFIZER
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.2.1 Overall Financials
10.14.2.2 Financials by Segment
10.14.2.3 Financials By Region
10.14.2.4 FINANCIAL SUMMARY
10.14.3 KEY DEVELOPMENTS
10.15 PHILIPS HEALTHCARE
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.2.1 Overall Financials
10.15.2.2 Financials By Region
10.15.2.3 Financials By Segment
10.15.2.4 Financial Summary
10.15.3 KEY DEVELOPMENTS
10.16 QUALCOMM, INC.
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.2.1 Overall Financials
10.16.2.2 Financials By Segment
10.16.2.3 Financials By Region
10.16.2.4 Financial Summary
10.16.3 KEY DEVELOPMENTS
10.17 QUEST DIAGNOSTICS INC.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.2.1 Overall Financials
10.17.2.2 Financials by Segment
10.17.2.3 Financial Summary
10.17.3 KEY DEVELOPMENTS
10.18 ROCHE HOLDING AG-BR
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.2.1 Overall Financials
10.18.2.2 Financials by Segment
10.18.2.3 Financial Summary
10.18.3 KEY DEVELOPMENTS
10.19 SAMSUNG ELECTRONICS CO. LTD.
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.2.1 Overall financials
10.19.2.2 Financial Summary
10.19.3 KEY DEVELOPMENTS
10.2 SANOFI PHARMA
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.2.1 Overall Financials
10.20.3 FINANCIALS BY SEGMENT
10.20.4 FINANCIAL SUMMARY
10.20.5 KEY DEVELOPMENTS
10.21 WITHINGS SAS
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 KEY DEVELOPMENTS
 
LIST OF TABLES
TABLE 1L EADING COMPANIES IN THE MHEALTH MARKET
TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2020-2027)
TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS
TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
TABLE 5 CONSORTIUMS IN MHEALTH MARKET
TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET
TABLE 7 REGULATORY BODIES IN MHEALTH MARKET
TABLE 8 MHEALTH MARKET CERTIFICATIONS
TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER
TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER
TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE
TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT
TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION
TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2020-2027 ($MILLION)
TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2020-2027 ($MILLION)
TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2020-2027 ($MILLION)
TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2027-2027 ($MILLION)
TABLE 19 KEY DEVELOPMENTS
TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS
TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT
TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 25 TYPE OF APP
TABLE 26 KEY DEVELOPMENTS
TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 29 KEY DEVELOPMENTS
TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 42 REMOTE MONITORING IN GEOGRAPHIES
TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2027-2027 ($MILLION)
TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2027-2027 ($MILLION)
TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES
TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2027-2027 ($MILLION)
TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES
TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES
TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES
TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)
TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 62 MHEALTH: KEY DEVELOPMENTS (2020- 2027)
TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)
TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)
TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 67 THE U.S.: KEY DEVELOPMENTS
TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2020-2027)
TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 71 KEY DEVELOPMENTS IN APAC
TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT
TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)
TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)
TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)
TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS (2020-2027)
TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2020-2027)
 
LIST OF FIGURES
FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA
FIGURE 2 XX RESEARCH METHODOLOGY
FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET
FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY
FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2020-2027 ($MILLION)
FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2020-2027 ($MILLION)
FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2020-2027 ($MILLION)
FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2020-2027 ($MILLION)
FIGURE 9 MARKET DRIVERS AND CHALLENGES
FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS
FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS
FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS
FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS
FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS
FIGURE 15 VALUE CHAIN
FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS
FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES
FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS
FIGURE 19 MHEALTH ECOSYSTEM
FIGURE 20 TYPE OF MHEALTH DEVICES
FIGURE 21 SMBD DEVICE USES
FIGURE 22 USES OF BP MONITORING DEVICE
FIGURE 23 PULSE OXIMETER USES
FIGURE 24 WEARABLE DEVICE COMPONENTS
FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES
FIGURE 26 HAND WORN MHEALTH DEVICES
FIGURE 27 APPLE WATCH FIGURE
FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS
FIGURE 29 GOOGLE’S CONTACT LENS
FIGURE 30 HEAD WORN DEVICES
FIGURE 31 ELECTRONIC FINGERTIP
FIGURE 32 COMPONENTS OF BIOSTAMP
FIGURE 33 MYO ARMBAND BY THALMIC LABS
FIGURE 34 NON-CLINICAL BENEFITS
FIGURE 35 WEARABLE MEDICAL DEVICES
FIGURE 36 FITNESS TRACKING DEVICES
FIGURE 37 TYPES OF MHEALTH SERVICES
FIGURE 38 TYPES OF APPS
FIGURE 39 BENEFITS OF BIG DATA
FIGURE 40 BENEFITS OF NETWORK & SERVICES
FIGURE 41 ROLES OF MOBILE OPERATORS
FIGURE 42 ROLE OF HEALTHCARE PROVIDERS
FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS
FIGURE 44 BENEFITS OF MHEALTH IN CVDS
FIGURE 45 BENEFITS OF MHEALTH
FIGURE 46 BENEFITS OF MHEALTH
FIGURE 47 BENEFITS OF MHEALTH
FIGURE 48 BENEFITS OF MHEALTH
FIGURE 49 TYPES OF MHEALTH APPLICATION
FIGURE 50 ADVANTAGES OF REMOTE MONITORING
FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES
FIGURE 52 EDUCATION & AWARENESS SERVICES
FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT
FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY
FIGURE 55 APAC: MARKET DRIVERS
FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2020)
FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS (2020)
FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2020)
FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2020)
FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS (2020)
FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2020-2027
FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2020-2027
FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2020-2027
FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2020-2027 ($MILLION)
FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)
FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2020-2027
FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2020-2027
FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2020-2027
FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027
FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2020-2027
FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027
FIGURE 72 GE HEALTHCARE SEGMENT, 2027
FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2020 - 2027 ($BILLION)
FIGURE 74 J&J: OVERALL FINANCIALS, 2020 - 2027 ($ BILLION)
FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2020-2027
FIGURE 76 NET REVENUE BY SEGMENTS, 2020-2027
FIGURE 77 NIKE: OVERALL FINANCIALS 2020 - 2027 ($BILLION)
FIGURE 78 NIKE: REVENUE BY REGION (2020-2027)
FIGURE 79 PFIZER: OVERALL FINANCIALS, 2020-2027 ($BILLION)
FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)
FIGURE 81 PFIZER: FINANCIALS BY REGION, 2020-2027 ($BILLION)
FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2020-2027 ($MILLION)
FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2020-2027 ($MILLION)
FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)
FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2020-2027 ($BILLION)
FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)
FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2020-2027 ($MILLION)
FIGURE 88 QUEST: OVERALL FINANCIALS, 2020-2027 ($MILLION)
FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2020-2027 ($MILLION)
FIGURE 90 ROCHE: OVERALL FINANCIALS, 2020-2027 ($BILLION)
FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2020-2027 ($BILLION)
FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2020-2027
FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2020-2027
FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2020-2027
mHealth Market
mHealth Market Size is Register at 36.5%CAGR to Reach US $ 21.71Billion during the forecast period.
$21.71Billion
Market Size
36.5%
CAGR
North America
Dominating Region
2020-2027
Forecast Period
Segmentation
Key Players
- Bayer healthcare
- Medtronic plc
- Samsung Group
- Sanofi
- Omron Corporation
- Boston Scientific Corporation
- Johnson and Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Dexcom
Drivers
- Benefits of Cost effectiveness and patients’ convenience
- Increase in lifestyle diseases
mHealth Market Overview
mHealth market share is expected to grow at 36.5% CAGR during the forecast period. mHealth is defined as a separate branch of eHealth that handles patient data collection. This patient data is collected via wireless electronic means such as mobile phones, wearables, and other mHealth devices. In addition, the collected patient data is stored remotely in the cloud using the mHealth application. This stored data will be available to healthcare professionals to analyze health-related parameters. For example, the mHealth blood pressure monitor collects data about patient blood pressure fluctuations. A medical professional immediately checks these values to determine the severity of the illness. In addition, various types of medical devices and services are on the market.
As people become more aware of personal health care, patients focus on their clinical picture and provide relevant information about their needs. The mobile and electronics industries are also focused on developing smartphones, watches, and other wearable devices. Medical prisoners are also investing in these variables that drive the mHealth market to tremendous growth.
COVID 19 Analysis
The arrival of the Covid-19 pandemic has accelerated growth for the medical and healthcare services to a great extent. However, the other industries are struggling with this new change and taking their time to implement them across various industries. The production, manufacturing, and delivery units have suffered the most owing to the travel, operational, and lockdown restrictions. The pandemic has hit the lives of people making them do every step that boosts their immunity. Also, the people who have contracted the illness are either in hospitals or home quarantine. To treat the patients and cure this illness along with others, the patients’ record is a must. This is because the treatment of the patients and the risk quotient are understood with the help of the same.
The mHealth market devices are being manufactured for wide use for the patients. The collected data through the services of the mHealth market helps in curing the patients and hence, is undergoing development. The key market players are investing in the research and development departments for devices and services to benefit patients and helping them receive the best possible treatment. Also, the government is showing support towards the global growth of the mHealth market with its offered schemes and regulations.
mHealth market, by Region (%)
Market Dynamics
Drivers
Owing to the increased awareness amongst people for personal healthcare, the patients are getting involved in-depth for their medical condition and provide appropriate information on requirements. Also, the mobile and electronic industry is focusing on the same by developing smartphones, watches, alongside other wearable devices. Also, the healthcare industry inmates are investing in these variables which are helping the mHealth market to grow at a staggering rate.
Restraints
The mHealth market deals in collecting the medical and other important information related to the patient and any family history of diseases. But, while getting the information recorded, the patients feel insecure owing to security and privacy issues. The risk related to misuse and data leaks is high due to which fewer patients sign up for the same.
Technology Analysis
The development in technology and other scientific advancement has a lot of benefits in store for the healthcare services where collecting and recording the patient’s data holds foremost importance. The key market players are on their way towards the use of wireless technology and integrating the same with the healthcare devices that are employed in the process of data collection. The mHealth market is thus, aiming to put both the doctors and patients in a better state to treat and seek treatment.
Study Objectives
- To study the scope of growth of the mHealth market after the pandemic and discussing the drivers and restraints available to the market after considering the viewpoint of the industry leaders and experts
- To analyze the mHealth market segments functional in different locations across the world and also have an idea about the companies that provide similar services to the potential clients
- To understand the potential of the market by analyzing the competitive degree prevailing and also considering the steps undertaken by the players towards global growth by the end of the forecast period in 2022
Segment Overview
To cater to a larger audience and expand its lane of operations, the mHealth market size has been segmented based on the devices, services, stakeholders, applications, along with the global regions. The sub-segmentation is as follows:
Device
Based on the devices, the mHealth market has devices like blood glucose meters, cardiac, neurological, and BP monitors, along with others like wearable fitness sensor devices, and heartbeat meters amongst others. These are both being demanded by the healthcare professionals and patients and further, produced by the key market players in various regions.
Service
The services that are offered through the mHealth market are prevention services, alongside others like monitoring and diagnostics, treatment, surgeries, wellness, and strengthening solutions for healthcare systems.
Stakeholders
The stakeholder segment of the mHealth market includes mobile operators, healthcare service providers, content players, and device vendors.
Application
The application segment of the mHealth market includes diseases like cardiovascular diseases, respiratory issues, diabetes, and neurological issues amongst others. The patients who suffer from these have a higher risk and thus, medical condition information and reports are a must to be collected.
Regional Analysis
As per the mHealth market trends, the North American market enjoyed a major share in the market in 2019, and there is a similar expectation by the end of the forecast period in 2022. The main reason behind this is that the region is witnessing major growth in the rise of the population that is suffering from problems like diabetes, cardiovascular issues, and BP problems. Hence, to help the patients, the key market players in this region are focusing on the development of mobile health devices and services. The patients are thus, demanding the same which is staggering an excellent growth in the global mHealth market.
The fastest-growing region as per the prediction is the APAC region. The key market players that are functional in this region are focusing on creating and raising awareness related to mobile healthcare services and devices for the patients having major issues and need to visit the hospitals now and then.
Competitive Landscape
The mHealth market value is largely dependent on the efforts for growth, mergers, and acquisitions, to enhance their product lane, services, and global presence. Also, the growth opportunities and strategies by the market players have a role to play in determining the market valuation by the end of the forecast period in 2022. The prominent players of the market are as follows:
- Bayer healthcare
- Medtronic plc
- Samsung Group
- Sanofi
- Omron Corporation
- Boston Scientific Corporation
- Johnson and Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Dexcom
Recent Developments
In June 2022
To assist in the resource selection process, the U.S. Department of Health Research and Quality (AHRQ) has published a brief description entitled "Evaluating Mental Health Mobile Applications" to allow healthcare professionals to choose the Mental Health mHealth App. With the new assignment, AHRQ aims to help providers, patients, and payers choose mobile mental health applications and find the best solution based on various features. According to AHRQ, choosing an app is often a hassle and requires a streamlined approach.
In June 2022
HelpAge India has announced the launch of three Mobile Healthcare Units (MHUs) in Telangana and West Uttar Pradesh with the support of the Mindtree Foundation, the CSR division of global technology consultancy and services company Mindtree. MHU has doctors, pharmacists, and social workers to provide medical services to the poor elderly in the immediate vicinity. The new MHU fleet will serve 30 new locations, with a total of more than 2000 locations served in 22 states.
Intended Audience
- Mobile operators and vendors
- Device vendors
- Application enthusiasts
- Content players
- Healthcare service providers and other staff
- Patients
Report Overview
The global mhealth market report discusses the impact of the pandemic on the market operations and depicts the dynamics like growth drivers and restraints on the way. The report considers the viewpoint of the industry experts and market leaders to procure the market insights that help in portraying a clear picture of the market for the forecast period ending in 2022. The report aims to help the investors and experts make better decisions and hence, the report discusses the market segmentation and their potential to meet the demand in the global regions they are currently functional in. Through the report, the aim is to study the competition prevailing in the market and for the same, the growth strategies by the market players are analyzed and the recent developments of the market for a global presence are also discussed.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 36.5% (2016-2022) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Therapeutics, Applications, End user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others. |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Mobile health or mHealth is the practice use of mobile devices for the purpose of health services, information, and data collection. mHealth has emerged as a booming field due to advancements in the use of information and communication technology (ICT), for health services and information.
The mHealth market is expected to reach USD 21.71BN by 2022.
The mHealth market is expected to register a whopping CAGR over 34% throughout the assessment period (2016-2022).
Implementation of smartphones and wearable devices into the healthcare industry.
North America holds the largest share in the mHealth market followed by Asia Pacific and Europe, respectively.
Alivecor, INC, Agamatrix, INC, Apple, INC, AT&T, INC, Athenahealth INC, Biotelemetry INC. (CARDIONET), Google INC, GE Healthcare, Jawbone INC, Laboratory Corporation of America Holdings, Johnson & Johnson, and Philips Healthcare are some of the major players operating in the global mHealth market.
